C
CEL-SCI Corp
AMEX:CVM
CEL-SCI Corp
AMEX:CVM
Price:
3.07
USD
-4.06%
Market Closed
Market Cap:
$26m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
CEL-SCI Corp
AMEX:CVM
|
US |
|
Atlantic Navigation Holdings (Singapore) Ltd
SGX:5UL
|
SG |
|
dentalcorp Holdings Ltd
TSX:DNTL
|
CA |
|
K
|
Kumpulan Fima Bhd
KLSE:KFIMA
|
MY |
|
C
|
China Dongsheng International Inc
OTC:CDSG
|
CN |
|
ABC-Mart Inc
TSE:2670
|
JP |
|
Alembic Ltd
NSE:ALEMBICLTD
|
IN |
|
VLS Finance Ltd
BSE:511333
|
IN |
|
Sri Havisha Hospitality and Infrastructure Ltd
NSE:HAVISHA
|
IN |
|
Ashmore Group PLC
LSE:ASHM
|
UK |
|
Saipem SpA
MIL:SPM
|
IT |
|
Hellenic Petroleum Holdings SA
OTC:HLPMF
|
GR |
|
Marksans Pharma Ltd
NSE:MARKSANS
|
IN |
|
Delorean Corporation Ltd
ASX:DEL
|
AU |
|
S
|
Sonam Clock Ltd
NSE:SONAMCLOCK
|
IN |
|
Titan International Inc
NYSE:TWI
|
US |
|
F
|
Fujian South Highway Machinery Co Ltd
SSE:603280
|
CN |
|
V
|
VT GMP Co Ltd
KOSDAQ:018290
|
KR |
|
Wiluna Mining Corporation Ltd
ASX:WMC
|
AU |
|
G
|
Giantec Semiconductor Corp
SSE:688123
|
CN |
|
Indiabulls Real Estate Ltd
NSE:IBREALEST
|
IN |
|
N
|
Nutrien Ltd
NYSE:NTR
|
CA |
|
S
|
Siav SpA
MIL:SIAV
|
IT |
|
Takeda Pharmaceutical Co Ltd
NYSE:TAK
|
JP |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of CVM.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CVM
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
CVM Competitors Multiples
CEL-SCI Corp Competitors
CEL-SCI Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
C
|
CEL-SCI Corp
AMEX:CVM
|
25.8m USD | 0 | -1.1 | -1.3 | -1.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD | 6.2 | 90 | 14.9 | 20.7 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD | 109.7 | -1 712.3 | 15 906.4 | -1 796.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.1B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD | 5.8 | 19.9 | 12.4 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.6B USD | 9.4 | 28.5 | 21.4 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD | 3.1 | 34.8 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
